• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Icon Plc (NQ: ICLR )

    212.27 +0.09 (+0.04%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Icon Plc

    < Previous 1 2 3 4 5 6 Next >
    ICON Reports Third Quarter 2023 Results
    From ICON plc
    Via Business Wire
    Earnings Scheduled For October 25, 2023
    Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion. 
    Via Benzinga
    Earnings Preview: Icon
    Via Benzinga
    Lennox International To Rally 22%? Here Are 10 Top Analyst Forecasts For Tuesday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
    Via Benzinga
    ICON Secures Upgraded Credit Rating from S&P Global Ratings
    From ICON plc
    Via Business Wire
    Where Icon Stands With Analysts
    Via Benzinga
    5 Analysts Have This to Say About Icon
    Via Benzinga
    The Latest Analyst Ratings for Icon
    Via Benzinga
    3 Publicly Traded Companies Most at Risk of an AI Smackdown
    Investors should definitely look to sell these three companies at risk from AI. The businesses are poised to be undermined by the technology. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    ICON plc Schedules Third Quarter 2023 Earnings Conference Call
    From ICON plc
    Via Business Wire
    ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
    From ICON plc
    Via Business Wire
    Will Chart Analysts Notice Bad Omen on Icon's Chart
    Via Benzinga
    Baird Maintains Outperform Rating for Icon: Here's What You Need To Know
    Via Benzinga
    Where Icon Stands With Analysts
    Via Benzinga
    What 5 Analyst Ratings Have To Say About Icon
    Via Benzinga
    Uber Technologies, Blackstone And A Major Healthcare Company: CNBC's 'Final Trades'
    On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners said Uber Technologies, Inc. 
    Via Benzinga
    BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial
    From ICON plc
    Via Business Wire
    ICON plc to Present at the Baird Global Healthcare Conference
    From ICON plc
    Via Business Wire
    ICON PLC (NASDAQ: ICLR) Climbs to New 52-Week High
    Via Investor Brand Network
    ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
    From ICON plc
    Via Business Wire
    ICON Reports Second Quarter 2023 Results
    From ICON plc
    Via Business Wire
    First Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital Services
    From ICON plc
    Via Business Wire
    ICON plc Schedules Second Quarter 2023 Earnings Conference Call
    From ICON plc
    Via Business Wire
    ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One Platform
    From ICON plc
    Via Business Wire
    ICON plc Set to Join Russell 3000® Index
    From ICON plc
    Via Business Wire
    ICON plc to Attend Upcoming Investor Conferences
    From ICON plc
    Via Business Wire
    ICON releases its 2022 ICON Cares ESG Report
    From ICON plc
    Via Business Wire
    ICON Reports First Quarter 2023 Results
    From ICON plc
    Via Business Wire
    ICON plc Schedules First Quarter 2023 Earnings Conference Call
    From ICON plc
    Via Business Wire
    2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
    These companies strive to bring down the cost of developing new therapies. 
    Via The Motley Fool
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.